查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2070382

軟膠囊市場規模、佔有率、成長、全球產業分析、區域趨勢及2026-2034年預測

Softgel Capsules Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

軟膠囊市場成長要素

受營養保健品、膳食補充劑和先進藥物製劑需求不斷成長的推動，全球軟膠囊市場正經歷強勁成長。軟膠囊因其易於吞嚥、穩定性好、生物利用度高等優點，廣泛用於遞送維生素、ω-3脂肪酸、草藥萃取物、特殊成分和藥物製劑。消費者對預防醫學和健康產品的日益關注也進一步促進了全球市場的擴張。

市場規模與市場價值

2025年全球軟膠囊市場價值78.7億美元。預計到2026年，該市場將成長至83.2億美元，到2034年將達到134.6億美元，反映出製藥、營養保健品和化妝品產業強勁的長期需求。

到2025年，北美將引領市場，佔全球銷售額的35.58%，這得益於其成熟的膳食補充劑行業和強大的製藥生產基地。

市場趨勢

市場的主要趨勢之一是軟膠囊的廣泛應用，以提高活性成分的生物利用度。許多藥物和膳食補充劑成分的水溶性較低，限制了其吸收。軟膠囊技術透過以脂質或預先溶解的形式輸送成分，有助於克服這一難題。

2026年 3月，Sirio Europe 宣布推出 Life Chews，這是一種植物來源的咀嚼片輸送技術，專為脂溶性活性成分而設計，凸顯了其在軟膠囊輸送系統方面的持續創新。

市場促進因素

增加營養補充品和維生素的攝取量

隨著消費者對預防醫學的日益關注，維生素、omega-3補充劑、免疫力增強產品和草藥產品的需求顯著成長。軟膠囊因其服用方便、易於吞嚥且適用於液體和油性成分而廣受歡迎。

2025年10月，Caldic和Lonza Capsugel在北美達成獨家合作協議，目的是拓展營養保健品的應用領域。這顯示軟膠囊製劑的商業性重要性日益凸顯。

市場限制因素

與品管和穩定性相關的挑戰

軟膠囊的生產對膠囊殼的組成、填充劑的配方以及儲存條件都有嚴格的控制。生產商經常面臨洩漏、膠囊殼變形、交聯和溶解等挑戰，尤其是在高溫高濕環境下。

這些問題推高了生產成本，並需要進行廣泛的穩定性測試，這在一定程度上限制了市場成長。

市場機會

植物來源軟膠囊的需求日益成長

隨著純素食和植物來源飲食方式的日益普及，不含動物性成分的軟膠囊也迎來了新的市場機會。出於倫理、飲食和宗教等原因，消費者尋求明膠基產品的替代品。

為此，製造商投資澱粉基、普魯蘭膠和其他植物來源的軟膠囊技術，以滿足消費者的需求，同時提供可比較的性能和穩定性。

市場挑戰

原料和製造成本上漲

由於軟膠囊生產高度依賴明膠和特殊成分，因此該行業極易受到供應鏈中斷和原料價格波動的影響。此外，軟膠囊生產需要精密的生產設備和嚴格的環境控制，這增加了營運成本。

這些因素持續對利潤率構成壓力，並對全球製造商構成挑戰。

區域分析

北美洲

到2025年，北美市場規模達到28億美元，並繼續維持其最大區域市場的地位。營養補充劑的高消費量和完善的醫療保健基礎設施將繼續支撐該地區的成長。

歐洲

在歐洲，由於人口老化以及預防性醫療產品、維生素和保健品的消費量增加，需求仍然強勁。

亞太地區

亞太地區有望成為成長最快的地區之一，其成長動力來自可支配收入的增加、都市化的加快以及人們對營養補充劑認知的提高。

拉丁美洲、中東和非洲

由於醫療保健服務的改善以及消費者在健康和營養產品上的支出增加，這些地區經歷適度成長。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 新產品發布：依主要公司分類
  • 產業重大發展動態（合併、收購、合作、新產品和服務的推出等）
  • 主要國家和地區的監管趨勢
  • 概述：軟膠囊的新應用領域

第5章 2021-2034年全球軟膠囊市場分析、洞察與預測

  • 市場分析、洞察與預測：依類型
    • 明膠膠囊
    • 非動物源軟膠囊
      • 澱粉類
      • 普魯蘭膠
      • 其他
  • 市場分析、洞察與預測：依應用領域分類
    • 處方藥
    • OTC
    • 營養保健品
  • 市場分析、洞察與預測：依製造商
    • 製藥公司
    • 營養保健品公司
    • 其他
  • 分析、洞察與預測：依地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美軟膠囊市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章 歐洲軟膠囊市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪地那維亞
    • 其他歐洲國家

第8章 亞太地區軟膠囊市場分析、洞察與預測（2021-2034年）

  • 國家
    • 中國
    • 日本
    • 印度
    • 東南亞
    • 澳洲
    • 其他亞太國家

第9章 拉丁美洲軟膠囊市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章 中東和非洲軟膠囊市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市場佔有率分析（2025年）
  • 公司簡介
    • Capsugel（Lonza）
    • Sirio Pharma
    • Catalent Inc.
    • Hunan Er Kang Pharmaceutical Co., Ltd
    • Aenova Group GmbH
    • Fuji Capsule Co., Ltd.
    • Captek Softgel International Inc.
    • Curtis Health Caps SA
    • EuroCaps Ltd
    • ALCALA FARMA laboratories（SYNERLAB）
    • Cloverty.
Product Code: FBI103353

Growth Factors of softgel capsules Market

The global softgel capsules market is experiencing robust growth, driven by increasing demand for nutraceuticals, dietary supplements, and advanced pharmaceutical dosage forms. Softgel capsules are widely used for delivering vitamins, omega-3 oils, herbal extracts, specialty ingredients, and pharmaceutical formulations due to their ease of swallowing, improved stability, and enhanced bioavailability. Rising consumer awareness regarding preventive healthcare and wellness products is further supporting market expansion worldwide.

Market Size and Market Value

The global softgel capsules market was valued at USD 7.87 billion in 2025. The market is expected to grow to USD 8.32 billion in 2026 and is projected to reach USD 13.46 billion by 2034, reflecting strong long-term demand from pharmaceutical, nutraceutical, and cosmetic industries.

North America dominated the market in 2025, accounting for 35.58% of global revenue due to its well-established dietary supplement industry and strong pharmaceutical manufacturing base.

Market Trends

A major trend shaping the market is the growing use of softgel capsules to improve the bioavailability of active ingredients. Many pharmaceutical and nutraceutical compounds have poor water solubility, limiting absorption. Softgel technologies help overcome this challenge by delivering ingredients in lipid-based or pre-dissolved forms.

In March 2026, Sirio Europe introduced Life Chews, a plant-based chewable delivery technology designed for lipid-soluble active ingredients, highlighting ongoing innovation in softgel-based delivery systems.

Market Drivers

Rising Consumption of Nutraceuticals and Dietary Supplements

Growing consumer interest in preventive healthcare is significantly increasing demand for vitamins, omega-3 supplements, immunity boosters, and herbal products. Softgel capsules are highly preferred because they are convenient, easy to swallow, and suitable for liquid or oil-based ingredients.

In October 2025, Caldic and Lonza Capsugel entered an exclusive North American partnership to expand nutraceutical applications, demonstrating the growing commercial importance of softgel formulations.

Market Restraints

Quality Control and Stability Challenges

Softgel capsules require strict control over shell composition, fill formulation, and storage conditions. Manufacturers often face challenges such as leakage, shell deformation, cross-linking, and dissolution issues, particularly in high-temperature and humid environments.

These concerns increase production costs and require extensive stability testing, limiting market growth to some extent.

Market Opportunities

Growing Demand for Plant-Based Softgel Capsules

The increasing popularity of vegan and plant-based lifestyles is creating new opportunities for non-animal softgel capsules. Consumers are seeking alternatives to gelatin-based products due to ethical, dietary, and religious preferences.

Manufacturers are responding by investing in starch-based, pullulan-based, and other plant-derived softgel technologies that provide similar performance and stability while meeting consumer demands.

Market Challenges

Rising Raw Material and Manufacturing Costs

Softgel manufacturing depends heavily on gelatin and specialty ingredients, making the industry vulnerable to supply-chain disruptions and raw-material price fluctuations. In addition, softgel production requires sophisticated manufacturing equipment and strict environmental controls, increasing operational costs.

These factors continue to pressure profit margins and present challenges for manufacturers globally.

Segment Analysis

By Type

The gelatin capsules segment dominated the market in 2025 due to its widespread acceptance, manufacturing efficiency, and compatibility with various formulations. Meanwhile, the non-animal softgel segment is expected to witness the fastest growth as demand for vegan products rises.

By Application

The prescription medicines segment held the largest market share because pharmaceutical companies increasingly use softgels to improve drug absorption, patient compliance, and product differentiation.

By Manufacturers

Pharmaceutical companies accounted for the largest market share due to their extensive product portfolios, regulatory expertise, and investments in advanced drug-delivery technologies.

Regional Analysis

North America

North America generated USD 2.80 billion in 2025, maintaining its position as the largest regional market. High dietary supplement consumption and advanced healthcare infrastructure continue to support regional growth.

Europe

Europe is witnessing strong demand due to its aging population and growing consumption of preventive healthcare products, vitamins, and wellness supplements.

Asia Pacific

Asia Pacific is expected to emerge as one of the fastest-growing regions, supported by increasing disposable income, urbanization, and rising awareness of nutritional supplementation.

Latin America and Middle East & Africa

These regions are experiencing gradual growth due to expanding healthcare access and increasing consumer spending on wellness and nutritional products.

Competitive Landscape

Major companies operating in the softgel capsules market include:

  • Lonza
  • Sirio Pharma
  • Catalent Inc.
  • Hunan Er Kang Pharmaceutical Co., Ltd
  • Aenova Group GmbH

These companies are focusing on capacity expansion, technological innovation, strategic partnerships, and plant-based capsule development to strengthen their market positions.

Conclusion

The global softgel capsules market is positioned for significant growth, supported by rising demand for nutraceuticals, pharmaceuticals, and preventive healthcare products. The market is projected to expand from USD 7.87 billion in 2025 to USD 8.32 billion in 2026, reaching USD 13.46 billion by 2034. Increasing adoption of bioavailability-enhancing formulations, growing demand for plant-based capsules, and continuous innovation in drug delivery technologies will remain key growth drivers. Despite challenges related to manufacturing complexity and raw-material costs, expanding applications across healthcare and wellness industries are expected to create substantial opportunities for market participants throughout the forecast period.

Segmentation By Type, Application, Manufacturers, and Region

By Type * Gelatin Capsules

  • Non-Animal Softgel Capsules
    • Starches
    • Pullulan
    • Others
  • Prescription Medicines
  • OTC
  • Nutraceutical
  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Others

By Application * Prescription Medicines

  • OTC
  • Nutraceutical

By Manufacturers

  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Others

By Region * North America (By Type, Application, Manufacturers, and Country)

    • U.S.
    • Canada
  • Europe (By Type, Application, Manufacturers, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Application, Manufacturers, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Application, Manufacturers, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Application, Manufacturers, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. New Product Launches, By Key Players
  • 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, among others.)
  • 4.3. Regulatory Scenario, By Key Countries/Regions
  • 4.4. Overview: Emerging Application Areas of Softgel Capsules

5. Global Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Gelatin Capsules
    • 5.1.2. Non Animal Softgel Capsules
      • 5.1.2.1. Starches
      • 5.1.2.2. Pullulan
      • 5.1.2.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Prescription Medicines
    • 5.2.2. OTC
    • 5.2.3. Nutraceutical
  • 5.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 5.3.1. Pharmaceutical Companies
    • 5.3.2. Nutraceutical Companies
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Gelatin Capsules
    • 6.1.2. Non Animal Softgel Capsules
      • 6.1.2.1. Starches
      • 6.1.2.2. Pullulan
      • 6.1.2.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Prescription Medicines
    • 6.2.2. OTC
    • 6.2.3. Nutraceutical
  • 6.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 6.3.1. Pharmaceutical Companies
    • 6.3.2. Nutraceutical Companies
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Gelatin Capsules
    • 7.1.2. Non Animal Softgel Capsules
      • 7.1.2.1. Starches
      • 7.1.2.2. Pullulan
      • 7.1.2.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Prescription Medicines
    • 7.2.2. OTC
    • 7.2.3. Nutraceutical
  • 7.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 7.3.1. Pharmaceutical Companies
    • 7.3.2. Nutraceutical Companies
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Gelatin Capsules
    • 8.1.2. Non Animal Softgel Capsules
      • 8.1.2.1. Starches
      • 8.1.2.2. Pullulan
      • 8.1.2.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Prescription Medicines
    • 8.2.2. OTC
    • 8.2.3. Nutraceutical
  • 8.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 8.3.1. Pharmaceutical Companies
    • 8.3.2. Nutraceutical Companies
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Southeast Asia
    • 8.4.5. Australia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Gelatin Capsules
    • 9.1.2. Non Animal Softgel Capsules
      • 9.1.2.1. Starches
      • 9.1.2.2. Pullulan
      • 9.1.2.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Prescription Medicines
    • 9.2.2. OTC
    • 9.2.3. Nutraceutical
  • 9.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 9.3.1. Pharmaceutical Companies
    • 9.3.2. Nutraceutical Companies
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Gelatin Capsules
    • 10.1.2. Non Animal Softgel Capsules
      • 10.1.2.1. Starches
      • 10.1.2.2. Pullulan
      • 10.1.2.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Prescription Medicines
    • 10.2.2. OTC
    • 10.2.3. Nutraceutical
  • 10.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 10.3.1. Pharmaceutical Companies
    • 10.3.2. Nutraceutical Companies
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of the Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Capsugel (Lonza)
    • 11.2.2. Sirio Pharma
    • 11.2.3. Catalent Inc.
    • 11.2.4. Hunan Er Kang Pharmaceutical Co., Ltd
    • 11.2.5. Aenova Group GmbH
    • 11.2.6. Fuji Capsule Co., Ltd.
    • 11.2.7. Captek Softgel International Inc.
    • 11.2.8. Curtis Health Caps S.A.
    • 11.2.9. EuroCaps Ltd
    • 11.2.10. ALCALA FARMA laboratories (SYNERLAB)
    • 11.2.11. Cloverty.

List of Tables

  • Figure 1: Global Softgel Capsules Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034
  • Figure 2: Global Softgel Capsules Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Softgel Capsules Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Softgel Capsules Market Value Share (%), by Manufacturers, 2025 & 2034
  • Figure 5: Global Softgel Capsules Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Softgel Capsules Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 7: North America Softgel Capsules Market Value Share (%), by Type, 2025
  • Figure 8: North America Softgel Capsules Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 9: North America Softgel Capsules Market Value Share (%), by Application, 2025
  • Figure 10: North America Softgel Capsules Market Value (USD Billion), by Manufacturers, 2025 & 2034
  • Figure 11: North America Softgel Capsules Market Value Share (%), by Manufacturers, 2025
  • Figure 12: North America Softgel Capsules Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 13: North America Softgel Capsules Market Value Share (%), by Country, 2025
  • Figure 14: Europe Softgel Capsules Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 15: Europe Softgel Capsules Market Value Share (%), by Type, 2025
  • Figure 16: Europe Softgel Capsules Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 17: Europe Softgel Capsules Market Value Share (%), by Application, 2025
  • Figure 18: Europe Softgel Capsules Market Value (USD Billion), by Manufacturers, 2025 & 2034
  • Figure 19: Europe Softgel Capsules Market Value Share (%), by Manufacturers, 2025
  • Figure 20: Europe Softgel Capsules Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Softgel Capsules Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Softgel Capsules Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Softgel Capsules Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Softgel Capsules Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Softgel Capsules Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Softgel Capsules Market Value (USD Billion), by Manufacturers, 2025 & 2034
  • Figure 27: Asia Pacific Softgel Capsules Market Value Share (%), by Manufacturers, 2025
  • Figure 28: Asia Pacific Softgel Capsules Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Softgel Capsules Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 30: Latin America Softgel Capsules Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 31: Latin America Softgel Capsules Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Softgel Capsules Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 33: Latin America Softgel Capsules Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Softgel Capsules Market Value (USD Billion), by Manufacturers, 2025 & 2034
  • Figure 35: Latin America Softgel Capsules Market Value Share (%), by Manufacturers, 2025
  • Figure 36: Latin America Softgel Capsules Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Softgel Capsules Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Softgel Capsules Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Softgel Capsules Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Softgel Capsules Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Softgel Capsules Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Softgel Capsules Market Value (USD Billion), by Manufacturers, 2025 & 2034
  • Figure 43: Middle East & Africa Softgel Capsules Market Value Share (%), by Manufacturers, 2025
  • Figure 44: Middle East & Africa Softgel Capsules Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Softgel Capsules Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 46: Global Softgel Capsules Market Share (%), by Company, 2025